Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (721-730 of 993) with videos related to

Pageof 100
Sort By:
European Urology Focus|September 25, 2025
Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological SubtypesMichele Nicolazzini, Mattia Longoni, Fabian Falkenbach, et al.
JAMA Oncology|October 2, 2025
Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical TrialColin Belliveau, Fred Saad, Danny Duplan, et al.
The Prostate|September 10, 2025
USPSTF Recommendation Against PSA Screening vs. Stage and Cancer-Specific Mortality in Localized Prostate CancerFabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Minerva Urology and Nephrology|November 4, 2024
Validation of lymphovascular invasion as a predictor of lymph-node invasion in squamous cell carcinoma of the penisLetizia M Jannello, Mario De Angelis, Carolin Siech, et al.
Journal of Surgical Oncology|June 6, 2022
Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patientsBenedikt Hoeh, Rocco S Flammia, Lukas Hohenhorst, et al.
The Lancet. Oncology|September 15, 2023
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trialFred Saad, Noel W Clarke, Mototsugu Oya, et al.
Urologic Oncology|November 18, 2019
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working groupVivek Narayan, Michael Harrison, Heather Cheng, et al.
Clinical Genitourinary Cancer|September 18, 2022
Mortality According to Treatment in Metastatic Collecting Duct Renal Cell CarcinomaAndrea Panunzio, Gabriele Sorce, Stefano Tappero, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2022
Radical cystectomy in non-metastatic sarcomatoid bladder cancer: A direct comparison vs urothelial bladder cancerStefano Tappero, Andrea Panunzio, Lukas Hohenhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge ConferenceRobert E Coleman, Theresa A Guise, Allan Lipton, et al.
Pageof 100

Showing results (721-730 of 993) with videos related to

Sort By:
Pageof 100
European Urology Focus|September 25, 2025
Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological SubtypesMichele Nicolazzini, Mattia Longoni, Fabian Falkenbach, et al.
JAMA Oncology|October 2, 2025
Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical TrialColin Belliveau, Fred Saad, Danny Duplan, et al.
The Prostate|September 10, 2025
USPSTF Recommendation Against PSA Screening vs. Stage and Cancer-Specific Mortality in Localized Prostate CancerFabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Minerva Urology and Nephrology|November 4, 2024
Validation of lymphovascular invasion as a predictor of lymph-node invasion in squamous cell carcinoma of the penisLetizia M Jannello, Mario De Angelis, Carolin Siech, et al.
Journal of Surgical Oncology|June 6, 2022
Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patientsBenedikt Hoeh, Rocco S Flammia, Lukas Hohenhorst, et al.
The Lancet. Oncology|September 15, 2023
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trialFred Saad, Noel W Clarke, Mototsugu Oya, et al.
Urologic Oncology|November 18, 2019
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working groupVivek Narayan, Michael Harrison, Heather Cheng, et al.
Clinical Genitourinary Cancer|September 18, 2022
Mortality According to Treatment in Metastatic Collecting Duct Renal Cell CarcinomaAndrea Panunzio, Gabriele Sorce, Stefano Tappero, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2022
Radical cystectomy in non-metastatic sarcomatoid bladder cancer: A direct comparison vs urothelial bladder cancerStefano Tappero, Andrea Panunzio, Lukas Hohenhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge ConferenceRobert E Coleman, Theresa A Guise, Allan Lipton, et al.
Pageof 100